| Accession |
PRJCA016937 |
| Title |
A Phase I trial to evaluate the safety, tolerability, and pharmacokinetic characteristics of HS-10353 in adult subjects |
| Relevance |
Medical |
| Data types |
Metagenome
|
| Organisms |
Homo sapiens
|
| Description |
A randomized, double-blind, placebo-controlled Phase I trial evaluating the safety, tolerability, and pharmacokinetic profile of HS-10353 in Chinese adult subjects for treating depression |
| Sample scope |
Multiisolate |
| Release date |
2023-10-07 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Zhu
Luo (luozhu720@163.com)
|
| Organization |
West China Hospital Sichuan University |
| Submission date |
2023-05-12 |
